Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Understanding what surgical advanced practice providers want: A survey of autonomy, tasks, and training preferences across three institutions.

American journal of surgery·2026

Same author

Adjuvant Chemotherapy Use for Hormone Receptor-Positive, ERBB2-Negative Breast Cancer After RxPONDER Trial.

JAMA network open·2026

Same author

Projected Cancer Screening and Outcomes Under the 2025 Federal Medicaid Eligibility Restrictions.

JAMA oncology·2026

Same author

Insurance Churn and the COVID-19 Pandemic.

JAMA health forum·2025

Same author

Young People with Cancer: A Growing Population in Need of United Attention.

Current oncology reports·2025

Same author

Trends and Disparities in the Use of Immunotherapy for Triple-Negative Breast Cancer in the US.

JAMA network open·2025

Search research articles

Related Experiment Video

Updated: Aug 20, 2025

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy

Published on: July 3, 2014

De-Escalating Breast Cancer Therapy.

Mary A Varsanik¹, Sarah P Shubeck¹

¹Department of Surgery, University of Chicago, 5841 South Maryland Avenue, Chicago, IL 60637, USA.

The Surgical Clinics of North America

|November 21, 2022

Summary

De-escalating breast cancer therapy offers significant benefits, reducing treatment complications and avoiding unnecessary chemotherapy. Eliminating low-value interventions improves patient outcomes and lowers healthcare costs.

Keywords:

Breast cancer therapy Chemotherapy De-escalation Surgical management

More Related Videos

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

Related Experiment Videos

Last Updated: Aug 20, 2025

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy

Published on: July 3, 2014

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

Area of Science:

Oncology
Surgical Oncology
Medical Oncology

Background:

Breast cancer treatment de-escalation is crucial for improving patient outcomes.
Reducing treatment-related morbidity and complications is a key goal in oncology.
Identifying and eliminating low-value therapies can prevent overtreatment and associated harms.

Purpose of the Study:

To highlight the significant value of de-escalation strategies in breast cancer therapy.
To emphasize the benefits of avoiding unnecessary treatments like chemotherapy in select patient groups.
To underscore the negative consequences of interventions with minimal or no benefit, including financial toxicity.

Main Methods:

This study is a review and synthesis of existing literature on breast cancer treatment de-escalation.
Analysis of data regarding complications and morbidity associated with surgical and chemotherapeutic interventions.
Evaluation of the impact of low-value care cascades on patient outcomes and healthcare expenditures.

Main Results:

De-escalation in breast cancer therapy significantly reduces complications and morbidity.
Avoiding chemotherapy in specific populations leads to substantial patient benefit.
Eliminating ineffective interventions prevents unnecessary procedures and financial toxicity.

Conclusions:

De-escalation of breast cancer therapy is highly valuable, improving patient well-being.
Minimizing low-value care cascades is essential for reducing excess healthcare costs and financial toxicity.
Further research and implementation of de-escalation strategies are warranted in breast cancer management.